Medical Devices Investors & VC Firms

1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
EF EFung Capital	88🔒	Shenzhen	CN	Series A–Growth	—	+ Add to CRM
H. H.I.G. HealthBridge Partners SMTTMFMM12 people	88🔒	Miami	US	Growth	$5M – $40M	+ Add to CRM
LE Lewis & Clark Ventures THTSMRCM12 people · Leads rounds	88🔒	St. Louis	US	Seed–Series A	$2M – $3M	+ Add to CRM
LI Life Sciences Greenhouse Investments MWGRASHY12 people · Follows rounds	88🔒	Harrisburg	US	Pre-Seed–Series B	$250K – $500K	+ Add to CRM
NE NextLeap Ventures OARKYHDC15 people	88🔒	Herzliya	IL	Pre-Seed–Series A	—	+ Add to CRM
SC SCI Ventures ACICTLDB18 people	88🔒	London	GB	Seed–Series B	—	+ Add to CRM
SH Shackleton Ventures Ltd. HSSBDHLF6 people	88🔒	London	GB	Seed–Series A	$952.5K – $25.4M	+ Add to CRM
BI Bios Partners LWAGADJF17 people	88🔒	Fort Worth	US	Seed–Growth	—	+ Add to CRM
RD RDiscovery TIKNTKTT20 people · Leads rounds	88🔒	Tokyo	JP	Pre-Seed–Seed	—	+ Add to CRM
WA Wasatch Equity Partners AGSSBFCK11 people · Leads rounds	88🔒	Logan	US	Seed–Late Stage	$1M – $100M	+ Add to CRM
AM Amplitude Venture Capital AGBSMRMM16 people · Follows rounds	88🔒	Montreal	CA	Pre-Seed–Series B	—	+ Add to CRM
PS PsyMed Ventures DBGKMSGZ13 people	88🔒	Berkeley	US	Pre-Seed–Series A	—	+ Add to CRM
SO Sodero AAAPELGN19 people	88🔒	Nantes	FR	Seed–Late Stage	$162K – $5.4M	+ Add to CRM
CT CTI Life Sciences Fund L.P. DMKPLRST9 people · Follows rounds	88🔒	Montréal	CA	Seed–Late Stage	—	+ Add to CRM
GS GSR United Capital	88🔒	Beijing	CN	Seed–Growth	—	+ Add to CRM
DE Delin Ventures ILJHMSRB17 people	88🔒	London	GB	Pre-Seed–Seed	$216K – $2.2M	+ Add to CRM
ST Star51 Capital ARRWACJR16 people	88🔒	New York	US	—	—	+ Add to CRM
BR BrightEdge SCSCABFB15 people	88🔒	Atlanta	US	Pre-Seed–Late Stage	—	+ Add to CRM
LI LifeSci Venture Partners PYRCIKBA6 people · Follows rounds	88🔒	New York	US	Series A–Series C	—	+ Add to CRM
DE Deep Ocean Capital SGR S.P.A. DNEGPCCV17 people · Leads rounds	88🔒	Rome	IT	Seed–Series A	—	+ Add to CRM
IK IKJ Capital FBVFFJJN11 people · Follows rounds	88🔒	Palo Alto	US	Seed–Series A	—	+ Add to CRM
MÉ Mérieux Equity Partners DLJBQDTC14 people · Leads rounds	88🔒	Paris	FR	Seed–Growth	$3.2M – $86M	+ Add to CRM
TE Tenmile SBASMLAB11 people	88🔒	—	AU	Seed–Series B	—	+ Add to CRM
BI Bioventures Investors MGPFCTJL16 people · Leads rounds	88🔒	Westborough	US	Seed–Growth	$15M – $100M	+ Add to CRM

EFung Capital

ShenzhenSeries A–Growth

H.I.G. HealthBridge Partners

MiamiGrowth$5M – $40M

SMTTMFMM12 people

Lewis & Clark Ventures

St. LouisSeed–Series A$2M – $3M

THTSMRCM12 people

Life Sciences Greenhouse Investments

HarrisburgPre-Seed–Series B$250K – $500K

MWGRASHY12 people

NextLeap Ventures

HerzliyaPre-Seed–Series A

OARKYHDC15 people

SCI Ventures

LondonSeed–Series B

ACICTLDB18 people

Shackleton Ventures Ltd.

LondonSeed–Series A$952.5K – $25.4M

HSSBDHLF6 people

Bios Partners

Fort WorthSeed–Growth

LWAGADJF17 people

RDiscovery

TokyoPre-Seed–Seed

TIKNTKTT20 people

Wasatch Equity Partners

LoganSeed–Late Stage$1M – $100M

AGSSBFCK11 people

Amplitude Venture Capital

MontrealPre-Seed–Series B

AGBSMRMM16 people

PsyMed Ventures

BerkeleyPre-Seed–Series A

DBGKMSGZ13 people

Sodero

NantesSeed–Late Stage$162K – $5.4M

AAAPELGN19 people

CTI Life Sciences Fund L.P.

MontréalSeed–Late Stage

DMKPLRST9 people

GSR United Capital

BeijingSeed–Growth

Delin Ventures

LondonPre-Seed–Seed$216K – $2.2M

ILJHMSRB17 people

Star51 Capital

New York

ARRWACJR16 people

BrightEdge

AtlantaPre-Seed–Late Stage

SCSCABFB15 people

LifeSci Venture Partners

New YorkSeries A–Series C

PYRCIKBA6 people

Deep Ocean Capital SGR S.P.A.

RomeSeed–Series A

DNEGPCCV17 people

IKJ Capital

Palo AltoSeed–Series A

FBVFFJJN11 people

Mérieux Equity Partners

ParisSeed–Growth$3.2M – $86M

DLJBQDTC14 people

Tenmile

Seed–Series B

SBASMLAB11 people

Bioventures Investors

WestboroughSeed–Growth$15M – $100M

MGPFCTJL16 people

Data sourced from public filings and firms' own websites — see our methodology.